Ionically Cross-linked Pectin-alginate Hydrogel Beads for Prolonged Release of Glibenclamide
نویسندگان
چکیده
Background: Glibenclamide is a second-generation sulfonylurea extensively associated with the therapy of diabetes mellitus. A sustained release drug in gastrointestinal tract may aid maintaining therapeutic range for an extended period time. Alginate and pectin are two commonly used biopolymers field delivery favourable biodegradation biocompatibility. Materials Methods: In present study, pectin-alginate hydrogel beads were developed intestinal glibenclamide. barium ion (Ba+2) induced ionic gelation technique was employed synthesising pH sensitive by varying ratio sodium alginate pectin. The FTIR study confirmed compatibility between drugs polymers. evaluated scanning electron microscopic entrapment efficiency (DEE), bead size, swelling ratio, in-vitro dissolution study. Results: images exhibited hemispherical shaped cracked rough surfaces. DEE reported to vary 78.38 ± 1.17 % 92.08 0.64 %. mean size found be 668.81 2.10 μm 984.62 2.84 μm. dependent observed, which indicated restricted water uptake acidic medium increased alkaline pH. demonstrated increasing concentration up 12 h. Conclusion: findings successful development Ba+2 ions cross-linked
منابع مشابه
Process and Parameters Affecting Drug Release Performance of Prepared Cross-linked Alginate Hydrogel Beads for Ezetimibe
Objective: The objective of this study was to formulate an oral sustained release delivery system of ezetimibe mucoadhesive beads by ionic gelation technique based on sodium alginate used as a hydrophilic carrier in combination with carbopol 934P which acts as a rate modifier. Methods: Microbeads of ezetimibe were prepared using an easy method of ionotropic gelation by little modification while...
متن کاملSustained Release of Diltiazem Hydrochloride from Cross-linked Biodegradable IPN Hydrogel Beads of Pectin and Modified Xanthan Gum
Interpenetrating polymer network hydrogel beads of pectin and sodium carboxymethyl xanthan were prepared by ionotropic gelation with Al(+3) ions and covalent cross-linking with glutaraldehyde for sustained delivery of diltiazem hydrochloride. Fourier transform infrared spectroscopy, X-ray diffraction, differential scanning colorimetry and scanning electron microscopy were used to characterise t...
متن کاملSustained Release of Risedronate from PLGA Microparticles Embedded in Alginate Hydrogel for Treatment of Bony Lesions
Background: Inflammatory bone resorption in periodontitis can lead to tooth loss. Systemic administration of bisphosphonates such as risedronate for preventing bone resorption can cause adverse effects. Alginate hydrogel (ALG) and poly (lactic acid-co-glycolic acid) (PLGA) microparticles have been studied as drug delivery systems for sustained release of drugs. Therefore, the release pattern of...
متن کاملPhotochemical Patterning of Ionically Cross-Linked Hydrogels
Iron(III) cross-linked alginate hydrogel incorporating sodium lactate undergoes photoinduced degradation, thus serving as a biocompatible positive photoresist suitable for photochemical patterning. Alternatively, surface etching of iron(III) cross-linked hydrogel contacting lactic acid solution can be used for controlling the thickness of the photochemical pattering. Due to biocompatibility, bo...
متن کاملIonically Cross-Linked Polymer Networks for the Multiple-Month Release of Small Molecules
Long-term (multiple-week or -month) release of small, water-soluble molecules from hydrogels remains a significant pharmaceutical challenge, which is typically overcome at the expense of more-complicated drug carrier designs. Such approaches are payload-specific and include covalent conjugation of drugs to base materials or incorporation of micro- and nanoparticles. As a simpler alternative, he...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International journal of pharmaceutical investigation
سال: 2022
ISSN: ['2230-9713', '2230-973X']
DOI: https://doi.org/10.5530/ijpi.2022.4.81